Add to ORKGPatients with advanced cancer often suffer from cachexia, a debilitating and complex extreme weight loss syndrome which is also associated with shorter survival times. A pragmatic randomised controlled trial was conducted to determine whether an oral nutritional supplement containing the omega-3 fatty acid eicosapentaenoic acid (EPA) was able to improve quality of life and survival times of patients with advanced solid tumour cancer in a mixed tumour cancer type population
OBJECTIVE: Cachexia is a nutrient deficient condition affecting millions of cancer patients. Cancers...
Background & Aims: There are few well-designed studies evaluating the effect of oral nutrition suppl...
PubMedID: 19090549Background. The aim of nutritional therapy in cancer patients is to prevent weight...
Background- Cancer cachexia is a distressing weight loss syndrome commonly seen in advanced cancer p...
Background: The European Palliative Care Research Collaboration is developing clinical guidelines on...
Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and l...
Journal Article; Research Support, Non-U.S. Gov't; Review;Use of n-3 fatty acids (FA) has been repor...
PURPOSE: Studies suggest eicosapentaenoic acid (EPA), an omega-3 fatty acid, augments weight, appeti...
Abstract: Cancer cachexia is an involuntary weight loss of more than 10 % of premorbid weight, caus...
Objective: Gastrointestinal (GI) cancer patients often experience severe malnutrition during cancer ...
Cachexia is a frequent problem in cancer patients associated with mortality and morbidity since it c...
A systematic review on the role of fish oil for the treatment of cachexia in advanced cancer: An EPC...
Cancer cachexia is a syndrome characterized by high prevalence and multifactorial etiology. The path...
The development of cachexia is common in people with solid tumours such as pancreatic, lung, gastric...
Background: Therapy-induced mucositis and dysphagia puts head and neck (H&N) cancer patients at incr...
OBJECTIVE: Cachexia is a nutrient deficient condition affecting millions of cancer patients. Cancers...
Background & Aims: There are few well-designed studies evaluating the effect of oral nutrition suppl...
PubMedID: 19090549Background. The aim of nutritional therapy in cancer patients is to prevent weight...
Background- Cancer cachexia is a distressing weight loss syndrome commonly seen in advanced cancer p...
Background: The European Palliative Care Research Collaboration is developing clinical guidelines on...
Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and l...
Journal Article; Research Support, Non-U.S. Gov't; Review;Use of n-3 fatty acids (FA) has been repor...
PURPOSE: Studies suggest eicosapentaenoic acid (EPA), an omega-3 fatty acid, augments weight, appeti...
Abstract: Cancer cachexia is an involuntary weight loss of more than 10 % of premorbid weight, caus...
Objective: Gastrointestinal (GI) cancer patients often experience severe malnutrition during cancer ...
Cachexia is a frequent problem in cancer patients associated with mortality and morbidity since it c...
A systematic review on the role of fish oil for the treatment of cachexia in advanced cancer: An EPC...
Cancer cachexia is a syndrome characterized by high prevalence and multifactorial etiology. The path...
The development of cachexia is common in people with solid tumours such as pancreatic, lung, gastric...
Background: Therapy-induced mucositis and dysphagia puts head and neck (H&N) cancer patients at incr...
OBJECTIVE: Cachexia is a nutrient deficient condition affecting millions of cancer patients. Cancers...
Background & Aims: There are few well-designed studies evaluating the effect of oral nutrition suppl...
PubMedID: 19090549Background. The aim of nutritional therapy in cancer patients is to prevent weight...